TALLAHASSEE, Fla., Jan. 29, 2026 — (CSE: ) (OTCQX: ) (“Trulieve” or “the Company”), a leading U.S. cannabis firm with strong performance, today revealed that following its December 17, 2025 update, it has completed the second tranche of its previously disclosed private placement of 10.5% Senior Secured Notes due 2030 (the “Notes”) for a principal sum of US$60.0 million (the “Offering”). Combined with the initial Notes offering that closed on December 17, 2025, Trulieve has issued Notes totaling US$200.0 million in principal. Each Note was issued at US$1,000 plus accrued but unpaid interest of US$12.37 per US$1,000 principal, covering the period from December 17, 2025 to January 29, 2026, and carries the same terms as those issued on December 17, 2025.

The Offering was carried out on a “best-efforts” basis under the terms of an agency agreement between the Company and Canaccord Genuity Corp., acting as sole agent and sole bookrunner. Trulieve will submit the necessary filings to list the Notes on the Canadian Securities Exchange (the “CSE”) after the four-month Canadian statutory hold period expires.

The Company plans to allocate the net proceeds from the Offering toward capital expenditures and other general corporate needs.

The offering and sale of the Notes have not been, and will not be, registered under the U.S. Securities Act of 1933 (as amended, the “Securities Act”) or the laws of any other jurisdiction. This news release does not constitute an offer to sell, a solicitation of an offer to buy, or a sale of the Notes in any state or jurisdiction where such an offer, solicitation, or sale would be illegal.

Forward-Looking Statements
This news release contains forward-looking information and statements as defined under the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements pertain to the Company’s expectations, forecasts, plans, intentions, estimates, and beliefs—including statements about the intended use of the Offering’s net proceeds, the listing of the Notes on the CSE, and other matters. Words like “expects,” “continue,” “will,” “anticipates,” and “intends,” or similar phrases, are used to identify forward-looking statements. These statements are based on the Company’s current projections and expectations regarding future events and trends that management believes could impact its financial standing, operating results, business strategy, and capital requirements. They also rely on assumptions and analyses the Company has made based on its experience, perception of historical trends, current conditions, expected future developments, and other factors management deems appropriate. Forward-looking information and statements involve assumptions and are subject to known and unknown risks, uncertainties, and other factors that may cause the Company’s actual events, results, performance, or achievements to differ materially from those expressed or implied by these statements. These factors include, but are not limited to, the risks outlined under “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, its subsequent periodic filings with the U.S. Securities and Exchange Commission, and its filings on SEDAR+ at . No assurance can be given that any forward-looking information or statements here will be accurate. Readers are advised to conduct their own assessment of these risks and uncertainties and should not place excessive reliance on such forward-looking statements. All forward-looking information and statements in this release are made as of the date hereof. Except as required by applicable law, the Company has no obligation to update or revise these statements, or to update the reasons actual results could differ from projections, whether due to new information, future events, or other factors.

About Trulieve
Trulieve is a leading, vertically integrated U.S. cannabis company and multi-state operator, holding top market positions in Arizona, Florida, and Pennsylvania. The company is positioned for rapid growth and expansion, scaling its retail and distribution footprint in new and existing markets via its hub strategy. By offering innovative, high-quality products across its brand lineup, Trulieve delivers exceptional customer experiences, expands cannabis access, and empowers patients and customers to live without constraints. Trulieve is listed on the CSE under the ticker TRUL and trades on the OTCQX market under TCNNF. For additional details, visit .

Facebook:    
Instagram: 
X: 

Investor and Media Contact
Christine Hersey, Chief Corporate Affairs & Strategy Officer
+1 (424) 202-0210

SOURCE Trulieve Cannabis Corp.